多种病理过程对阿尔茨海默病风险的协同作用:依赖年龄的中风相互作用的证据
Fen Liu1, Xuesong Xia2, Chengjie Zheng3
1Department of Neurology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, No.134, Dong Street, Fuzhou 350001, Fujian Province, China.
The journal of prevention of Alzheimer's disease
|July 16, 2025
概括
综合性病理负担评分 (PBS) 显示,与阿尔茨海默病 (AD) 风险有很强的联系,因中风史和年龄显著恶化. 积极的血管风险管理至关重要,尤其对年轻人来说.
科学领域:
- 神经病理学神经病理学
- 老年学是指老年学的学科.
- 流行病学 流行病学
背景情况:
- 阿尔茨海默病 (AD) 的发病过程复杂,涉及多种相互作用的病理和脑血管因素.
- 传统的AD研究往往侧重于单个标志物,忽视累积的病理效应及其与年龄的相互作用.
- 了解神经病理和血管健康的综合影响对于有效的AD风险评估至关重要.
研究的目的:
- 开发一个全面的病理负担评分 (PBS),整合多种神经病理和脑血管标志物.
- 调查PBS发育和阿尔茨海默病 (AD) 风险之间的关系.
- 检查中风史和年龄对PBS和AD风险之间的关联的相互作用影响.
主要方法:
- 来自国家阿尔茨海默氏症协调中心数据库的11,308名参与者的分析.
- 一个PBS的构建,包括Braak阶段,CERAD分数,Thal阶段,中风史,白质稀缺和脑缩.
- 多变量逻辑回归和相互作用分析,按年龄分层 (75年截止点).
主要成果:
- 在PBS和AD风险之间发现了显著的剂量反应关系;与低负担相比,非常高的负担增加了几率的五倍以上.
- 脑卒中史显著放大了病理负担对AD风险的影响 (相互作用OR 1.23,p < 0.001).
- 年龄相关的效应明显,年轻人 (<75岁) 患有高负担和中风的几率明显高于老年人 (≥75岁).
结论:
- 累积的病理负担是AD风险的强有力的预测因素,中风史作为一个显著的放大器.
- 针对年龄的预防策略至关重要,强调血管风险管理,特别是在年轻人群中.
- 综合性病理负担评估可以提高AD风险分层,并为个性化痴呆症护理提供信息.
更多相关视频
相关概念视频
Alzheimer's Disease: Overview
673
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
673
Aging
188
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
188
Alzheimer's Disease: Treatment
263
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
263
Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K
Parkinson's Disease: Overview
715
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
715


